Equillium Inc (EQ)
1.46
-0.06
(-3.95%)
USD |
NASDAQ |
May 01, 16:00
1.46
0.00 (0.00%)
After-Hours: 19:45
Equillium Revenue (Quarterly): 9.211M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 9.211M |
September 30, 2023 | 8.87M |
June 30, 2023 | 9.124M |
Date | Value |
---|---|
March 31, 2023 | 8.879M |
December 31, 2022 | 15.76M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
8.87M
Minimum
Sep 2023
15.76M
Maximum
Dec 2022
10.37M
Average
9.124M
Median
Jun 2023
Revenue (Quarterly) Benchmarks
Janux Therapeutics Inc | 2.461M |
Retractable Technologies Inc | 14.29M |
Mersana Therapeutics Inc | 10.70M |
Spero Therapeutics Inc | 71.82M |
Vera Therapeutics Inc | -- |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -2.342M |
Total Expenses (Quarterly) | 12.41M |
EPS Diluted (Quarterly) | -0.07 |
Enterprise Value | 12.72M |
Profit Margin (Quarterly) | -25.43% |
Earnings Yield | -26.71% |
Normalized Earnings Yield | -26.71 |